The role of radioactive iodine therapy in young patients with papillary thyroid cancer

Clinical Nuclear Medicine

Volumn 34, Issue 1, 2009, Pages 4-6

  Kuo, Sheng Fong ^a   Chao, Tzu Chieh ^a   Chang, Hung Yu ^a   Hsueh, Chuen ^a   Chang, Yu Chen ^a   Yang, Chung Han ^a   Lin, Jen Der ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Flipflop phenomenon; Papillary thyroid cancer; Pediatric; Radioactive iodide

Indexed keywords

IODINE 131; THYROGLOBULIN; RADIOACTIVE IODINE;

ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MEDICAL RECORD; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRESCHOOL CHILD; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; TAIWAN; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; ADOLESCENT; METASTASIS; PATHOLOGY; THYROID TUMOR; TREATMENT OUTCOME; WHOLE BODY IMAGING;

ADOLESCENT; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM METASTASIS; THYROID NEOPLASMS; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 59649120730     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31818f455e     Document Type: Article

References (8)

1. Cooper DS, Doherty GM, Haugen BR, et al. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.
2. Pacini F, Schlumberger M, Dralle H, et al. European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803.
3. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer. 2005;12:773-803.
4. Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892-2899.
5. Lin JD, Hsieh SH, Chang HY, et al. Outcome after treatment for papillary thyroid cancer. Head Neck. 2001;23:140-146.
6. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate analysis of prognostic variables. J Nucl Med. 1993;34:1626-1631.
7. Schlumberger MJ, Arcangioli O, Piekarski JD, et al. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays. J Nucl Med. 1988;29:1790-1794.8.
8. Feine U, Leitzenmayer R, Hanke JP, et al. Fluorine-18-FDG and Iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996;37:1468-1472.